Enhancement of genetic instability in human B cells by Epstein–Barr virus latent infection

By Gualandi G.   Giselico L.   Carloni M.   Palitti F.   Mosesso P.   Alfonsi A.M.  

Mutagenesis, Vol. 16, Iss. 3, 2001-05 ,pp. : 203-208

Oxford University Press

Access to resources Recommend Favorite

Epstein–Barr Virus Plasmid Model System for Analyzing Recombination in Human Cells

By Phillips J.E.   Thyagarajan B.   Calos M.P.  

Plasmid, Vol. 41, Iss. 3, 1999-05 ,pp. : 198-206

Academic Press

Access to resources Recommend Favorite

Analysis of a YAC with human telomeres and oriP from Epstein–Barr virus in yeast and 293 cells

By Tolmachova Tanya   Simpson Kaetrin   Huxley Clare  

Nucleic Acids Research, Vol. 27, Iss. 18, 1999-09 ,pp. : 3736-3744

Oxford University Press

Access to resources Recommend Favorite

Interleukin-12 Expression in B Cells by Transformation with Epstein–Barr Virus

By Yoshimoto T.   Nagase H.   Yoneto T.   Inoue J-I.   Nariuchi H.  

Biochemical and Biophysical Research Communications, Vol. 252, Iss. 3, 1998-11 ,pp. : 556-560

Elsevier

Access to resources Recommend Favorite

Efficient Gene Delivery into Epstein–Barr Virus (EBV)-Transformed Human B Cells Mediated by Replication-Defective Herpes Simplex Virus-1 (HSV-1): A Gene Therapy Model for EBV-Related B Cell Malignancy

By Suzuki T.   Piche A.   Kasono K.   Xiang J.   Gomez-Navarro J.   Moriuchi S.   Krisky D.M.   Oligino T.   Glorioso J.C.   Curiel T.J.   Curiel D.T.  

Biochemical and Biophysical Research Communications, Vol. 252, Iss. 3, 1998-11 ,pp. : 686-690

Elsevier

Access to resources Recommend Favorite